Circulating Tumor DNA Predicts Early Treatment Response in Patients With HER2-Positive CancersApril 12, 2024Neuro-oncology
Less Than 50% of Accelerated Approvals Show Clinical BenefitApril 9, 2024Mixed TopicsNeuro-oncologyGene TherapyPediatrics
Virtual Reality Brings Relief to Hospitalized Patients With CancerApril 8, 2024PainPediatricsNeuro-oncology
Should Opioids Be Used for Chronic Cancer Pain?April 5, 2024Fast Facts FridayNeuro-oncologyMixed TopicsPediatricsBusiness of MedicinePain
It Takes a Village: Treating Patients for NSCLC Brain MetastasesMarch 29, 2024Neuro-oncologyMixed Topics
Most Cancer Trial Centers Located Closer to White, Affluent PopulationsMarch 21, 2024Neuro-oncologyMixed TopicsPediatricsBusiness of Medicine
Extraordinary Patients Inspired Father of Cancer ImmunotherapyMarch 19, 2024Mixed TopicsBusiness of MedicineNeuro-oncology
FDA Removes Harmful Chemicals From Food PackagingMarch 1, 2024Mixed TopicsPediatricsBusiness of MedicineNeuro-oncologyAlzheimer's & CognitionNeurodevelopmental Disorders
Moderate to Severe TBI Linked to Brain Cancer RiskFebruary 27, 2024Traumatic Brain InjuryNeuro-oncology
Democratic Lawmakers Press Pfizer on Chemotherapy Drug ShortagesFebruary 22, 2024Mixed TopicsNeuro-oncologyBusiness of MedicinePediatrics
Chemotherapy-induced peripheral neuropathy tied to compromised executive functionNovember 15, 2023Neuromuscular DisordersNeuro-oncology
Number of cancer survivors with functional limitations doubled in 20 yearsMay 11, 2023Diversity in MedicineMixed TopicsNeuro-oncology
